You are here: Industry Insights > novo

News List

Novo Nordisk licenses kidney disease drug from Epigen fiercebiotech
May 29, 2018
Novo Nordisk has picked up the worldwide rights to a kidney disease drug in development at Epigen.
Novo Nordisk increases commitment to stem cell-based therapies worldpharmanews
May 23, 2018
Novo Nordisk today announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes into other serious chronic diseases. This has been made possible
Novo cleared to add key data to Tresiba label pharmaphorum
March 29, 2018
Novo Nordisk can add data showing Tresiba can reduce the risk of hypoglycaemia to its label, a development which should help its fight competition from cheaper alternatives.
Sanofi, Novo back rare disease startup Inozyme in $49M round americanpharmaceuticacreview
November 16, 2017
The mission is to help babies with very rare disorders caused by mineral imbalances that can lead to overcalcification of soft tissues and undermineralization of bone, and can all too often cause death.
Novo's diabetes treatment semaglutide gets unanimous FDA backing pharmafile
October 20, 2017
Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one of the regulators advisory panels voting unanimously in favour of the drug’s approval.
Novo petitions FDA to require Victoza copies to go through clinical trials, pointing to complex manu fiercepharma
October 10, 2017
With one drugmaker already trying to pry patent protection off of Novo Nordisk’s blockbuster Victoza before its 2022 expiration, the insulin specialist has taken new steps to deter copies.
Novo’s semaglutide superior to Lilly’s Trulicity in diabetes trial pharmatimes
August 18, 2017
Novo Nordisk’s once-weekly diabetes drug semaglutide has beaten Eli Lilly’s once-weekly therapy dulaglutide on reducing blood sugar and weight in patients taking part in a late-stage trial.
Novo’s Saxenda label to include cardio data pharmaphorum
June 26, 2017
Novo’s Saxenda label to include cardio data
AbbVie, Novo, Takeda take home honors in pharma's latest reputation study fiercepharma
June 07, 2017
Which pharma company has the best reputation? Boston-based Reputation Institute has a few ideas.
Novo to buy 20% stake in UK’s ConvaTec pharmatimes
March 30, 2017
Novo A/S, the holding company for the Novo Group and fully owned subsidiary of the Novo Nordisk Foundation, has announced plans to acquire a 19.95 percent stake in UK medical...

Previous page 1 2 3 4 Next page